All leukemia lines tested displayed constitutive phosphorylation of STAT3/5 in the absence of serum, but only in cell lines carrying the JAK2V617F mutation was STAT3/5 phosphorylation inhibited following treatment with JAKi-I (Fig. 1C). This evidence concerns the gene STAT3 and leukemia.